Monday, July 26, 2021 12:39:37 PM
He was named one of the world's top 3% scientists four years in a row. The National Cancer Center selected Dr. Lee as "The Outstanding Scientist of the Year." He has published over 200 research papers, with approximately 90 through the Science Citation Index (SCI).
His research includes CBD research and SCI international cancer research papers. He developed a cancer drug using natural products, small molecular compounds and antibodies. Dr. Lee has fifteen registered patents.
Dr. Lee has brought to Kaiyon Biotech Inc. a consortium of prestigious scientists and researchers that share in his mission to discover, formulate, and license psilocybin and CBD medicines to be used in the treatment of dementia, schizophrenia, manic depression, sleep disorder, PTSD, cancer and autism.
According to Dr. Lee, the scientists hired at Kaiyon Biotech are each strategic for their contribution to research, and there is KFDA approval for studying psilocybin and CBD.
Dr. DaeHee Lee received a Master of Science and Doctorate of Philosophy in biotechnology and food science from Korea University at Seoul.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM